Mental health disparity between teenage boys and girls ‘not inevitable’ – study – The Independent

Mental health disparity between teenage boys and girls ‘not inevitable’ – study – The Independent

Notifications can be managed in browser preferences.
Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in
Mental health disparities between teenage girls and boys are “not inevitable”, experts have said.
The comments come after a new study compared the mental health of teenagers in London and Tokyo.
From early adolescence, girls from both London and Tokyo have higher levels of depression than boys.
But the “disparity is larger”, increases at a faster rate and starts earlier among girls in London.
And experts said that the “trajectory for boys in London closely mirrors the trajectory for girls in Tokyo”.
Researchers said their work suggests that differences in emotional health between teenage boys and girls are “not an inevitable part of teenage development”.
They suggested that if problems are driven by “social and structural factors” then individual solutions – including mindfulness, talking therapies and mental health first aid – are “unlikely to be effective” at resolving differences in emotional health between teenage boys and girls.
The new study, led by experts at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, tracked depressive symptoms in 7,100 people from Tokyo and London.
Experts monitored symptoms at three different points throughout adolescence among children aged 11 to 16.
“We found strong evidence that gender inequalities in depressive symptoms are larger, and might emerge earlier, among young people in London than young people in Tokyo,” the authors wrote in the journal Lancet Child And Adolescent Health.
“Notably, the mean rate of increase in depressive symptoms per year was around four times steeper among girls in London than girls in Tokyo.”
Young researchers who contributed to the study suggested that teenagers in London might assume adult roles and responsibilities at a younger age compared with young people in Tokyo
“In the UK, young girls and those in low income and financially insecure families assume adult responsibilities (eg unpaid care) at younger ages compared with boys and those from more affluent backgrounds,” the authors said, adding that “it is possible that (gendered) differences in young people’s roles and responsibilities in the home and the community contribute to disproportionately high depressive symptoms among girls in London”.
They said that societal differences may also contribute – for instance violence and “interpersonal crime” is lower in Tokyo than it is in London.
Young people in London may be more likely to experience racism, they said.
“And the UK’s prolonged period of austerity — and related increases in child poverty, inequality, and chronic underfunding of public services supporting young people — is not mirrored in Japan,” the authors added.
The study concludes: “Differences in emotional health between teenage boys and girls are often considered an inevitable part of teenage development; our own and others’ work increasingly suggests this might not be case.
“If high and rising rates of emotional ill-health among girls and young women are largely driven by social and structural factors, then individual-focused interventions (eg, mindfulness, talking therapies, and mental health first aid), which currently dominate the UK’s response to the problem, are unlikely to be an effective solution.
“Our findings suggest gender inequalities in emotional health are context dependent and the steep increases in emotional distress faced by many girls in the UK are not an inevitable part of development.
“There is an urgent need to understand the contexts and conditions that enable young girls to thrive.”
First author Dr Gemma Knowles, from King’s College London, said “Our study suggests that, from around early adolescence onwards, girls have higher levels of depression than boys in both Tokyo and London but the disparity is larger, starts a bit earlier, and increases at a faster rate in London.
“The trajectory for boys in London closely mirrors the trajectory for girls in Tokyo.
“These findings suggest we need to rethink and challenge popular narratives around gender differences in mental health – for example, the idea that girls are naturally or inevitably more likely to struggle with their emotional health – and to understand the contexts and conditions that enable teenage girls and young people to thrive.”
Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

source

Leave a Comment

Australia's 'biggest defence export' was meant to go to the US first, but Canada snuck past Donald Trump – ABC News

Australia's 'biggest defence export' was meant to go to the US first, but Canada snuck past Donald Trump – ABC News


Search the news, stories & people
Personalise the news and
stay in the know
Emergency
Backstory
Newsletters
中文新闻
BERITA BAHASA INDONESIA
TOK PISIN
Topic:Federal Government
Recently installed Canadian Prime Minister Mark Carney confirmed the $6.5 billion JORN purchase overnight. (AP: Justin Tang)
Canada was always meant to follow the United States in acquiring world-leading Australian radar technology but "things moved quickly" after Donald Trump won the US presidency.
Canada's Prime Minister Mark Carney confirmed the $6.5 billion JORN purchase overnight, after a conversation with Prime Minister Anthony Albanese.
Defence Minister Richard Marles says there are still some hurdles to clear, but the sale of the technology would be the biggest defence export in Australia's history.
For months, senior officials have been discussing exporting Australia's world-leading radar technology JORN to the United States, but after Donald Trump's return to the White House, Canada saw an opportunity and leapt.
Overnight, new Canadian leader Mark Carney spoke to his counterpart, Anthony Albanese, then flew to his country's Arctic territory of Nunavut to announce a $6.5 billion high-tech Australian military purchase.
"Today, I'm announcing that our government will be working with our long-standing defence and security partner Australia to build a new, long-range, over-the-horizon military radar system," he said.
"[It] will enable Canada to detect and respond to both air and maritime threats over our Arctic both faster and from further away. It will most fundamentally keep all Canadians safe."
Following President Trump's repeated threats to annex Canada and Greenland, Ottawa is purchasing the Australian-developed technology known as the Jindalee Over-the-Horizon Radar (JORN) to build its new Arctic Over-the-Horizon Radar system.
The Jindalee Over-the-Horizon Radar (JORN) has been in service for more than three decades. (BAE Systems)
Ottawa has been under pressure from Washington to step up its defence spending and the new radar system will support "NORAD", the joint US-Canadian initiative that detects incoming threats.
Now in its fourth decade of service, the high-frequency, sky-wave, over-the-horizon (OTHR) system is considered the most advanced in the world, providing wide-area surveillance of ships and aircraft out to 3,000 kilometres.
Unlike traditional radars that were limited by line of sight, Australian scientists designed JORN to beam a high-frequency radio signal skywards towards the ionosphere above the earth's surface, which then refracted the signal down to illuminate a target.
The echo from the target then travels by a similar path back to a separate receiver site and the data received is processed into real-time tracking information — a capability crucial to monitoring Australia's vast northern maritime approaches.
With the United States continuing its campaign of tariffs on foreign nations, Prime Minister Anthony Albanese said it was good for Australia to "diversify" its trade relationships.
"[Mark Carney] certainly spoke to me about the over-the-horizon radar technology that Canada is interested in purchasing from Australia, it's important that we diversify our trade relationships," Mr Albanese said.
"It's important that we develop that diverse series of relationships and Canada is a very important one, we have so much in common."
In recent meetings, senior Australian officials have continued discussing exporting and installing the JORN technology on the United States' west coast, but the massive project faces uncertainty under the Elon Musk-led DOGE audit of Pentagon spending.
For well over a year, American military officials have privately expressed interest in purchasing Australia's JORN technology because of its potential to monitor military movements as far away as China's mainland.
One senior Australian official confirmed to the ABC that "the Canadians were always going to follow the US purchase and slipstream off that" but circumstances changed and "things moved quickly".
Ottawa is purchasing Australia's Jindalee Over-the-Horizon Radar (JORN). (Department of Defence)
Following Canada's announcement, Defence Minister Richard Marles talked up the potential of the final JORN deal, which could end up being Australia's largest military export on record.
"There's a little water to go under the bridge, but what's in prospect here is potentially the biggest defence industry export that Australia has ever been a part of," he told ABC News Breakfast.
"That would obviously be very good for Australian industry."
The ABC has confirmed the United Kingdom, where the parent company of BAE Systems Australia is based, has also expressed interest in purchasing the JORN technology, but is yet to approve the idea.
Topic:Health Policy
Analysis by Brett Worthington
Topic:World Politics
Topic:Sexual Offences
Topic:Tariffs
Topic:Tariffs
Topic:Sexual Offences
Topic:World Politics
Aerospace and Defence Equipment Manufacturing
Australia
Defence Forces
Defence Industry
Federal Government
Foreign Affairs
Government and Politics
Topic:Health Policy
Analysis by Brett Worthington
Topic:World Politics
Topic:Sexual Offences
Topic:Tariffs
Topic:Health Policy
Topic:Fish
Topic:Courts
Topic:Courts
We acknowledge Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn, and work.
This service may include material from Agence France-Presse (AFP), APTN, Reuters, AAP, CNN and the BBC World Service which is copyright and cannot be reproduced.
AEST = Australian Eastern Standard Time which is 10 hours ahead of GMT (Greenwich Mean Time)

source

Leave a Comment

Gender gap in teenage depression is twice as large in London as in Tokyo, study finds – Medical Xpress

Gender gap in teenage depression is twice as large in London as in Tokyo, study finds – Medical Xpress


Forget Password?
Learn more
share this!
1
Tweet
Share
Email
March 18, 2025
This article has been reviewed according to Science X’s editorial process and policies. Editors have highlighted the following attributes while ensuring the content’s credibility:
fact-checked
trusted source
proofread
by
Published in The Lancet Child & Adolescent Health, the study aimed to provide robust insights into adolescent mental health trajectories in two different cultural contexts by comparing large samples of 11 to 16-years-olds in London and Tokyo over time.
The two studies are the Tokyo Teen Cohort (TTC) and the Resilience Ethnicity and Adolescent Mental Health (REACH) cohorts from South London. Both groups collected data in the period 2014 to 2020 and at three different timepoints as the teenagers grew older.
Researchers used the Short Mood and Feelings Questionnaire (SMFQ) to measure depressive symptoms.
In both groups there was a difference between teenage boys and girls in the average level of depressive symptoms and this difference widened year-on-year.
In the London sample, the gender difference started slightly earlier (evident by 11–12 years) than in the Tokyo sample where it emerged between 11 and 14 years, and the average rate of change in depressive symptoms per year in London girls was around four times greater than among girls in Tokyo.
By the age of 16, the difference in depressive symptoms between boys and girls in London was around twice as large as in Tokyo. The average level of depressive symptoms in teenage boys in Tokyo declined between the ages of 11 and 16, whereas for boys in London it increased slightly over time, following a similar trajectory to that of teenage girls in Tokyo.
First author, Dr. Gemma Knowles, Lecturer in Epidemiology and Youth Mental Health at IoPPN, King’s College London, said, “Our study suggests that from around early adolescence onward girls have higher levels of depression than boys in both Tokyo and London, but the disparity is larger, starts a bit earlier, and increases at a faster rate in London.
“The trajectory for boys in London closely mirrors the trajectory for girls in Tokyo. These findings suggest we need to rethink and challenge popular narratives around gender differences in mental health—for example, the idea that girls are naturally or inevitably more likely to struggle with their emotional health—and to understand the contexts and conditions that enable teenage girls and young people to thrive.”
Currently the Global Gender Gap Index (GGGI)—an index designed to measure gender equality—ranks the UK 15th out of 149 countries while Japan is ranked 125th. However, insights from young co-researchers from both cities suggest there are social influences at play which are not captured in these indexes.
For example, teenage girls may assume adult roles and responsibilities at a younger age in London and there are lower levels of violence and crime in Tokyo. There are also differences in socioeconomic and political trends between the two places that could contribute to differences, for example, the prolonged period of austerity in the UK.
Dr. Knowles said, “This is a complex area with a multitude of possible factors that may contribute to the difference between girls and boys and between the two places. We need to better understand the social contexts and experiences that give rise to gender inequalities in mental health and the conditions that support teenage girls to thrive.
“It’s also important to understand how these social experiences interplay with young people’s physical development at this age.”
An important part of this study was to investigate the extent to which scores derived from the measure SMFQ can be meaningfully and appropriately compared across genders, ages, and contexts.
While these tests are not perfect, they found no evidence of incomparable measurements, which suggests that any differences in SMFQ scores between groups are due to real differences in depressive symptoms rather than differences in reporting.
More information: Knowles G. et al. Trajectories of depressive symptoms among young people in London, UK, and Tokyo, Japan: a longitudinal cross-cohort study., The Lancet Child & Adolescent Health (2025). DOI: 10.1016/S2352-4642(25)00059-8
Explore further
Facebook
Twitter
Email
Feedback to editors
54 minutes ago
0
1 hour ago
0
23 hours ago
1
Mar 17, 2025
2
Mar 16, 2025
0
54 minutes ago
1 hour ago
14 hours ago
14 hours ago
14 hours ago
16 hours ago
16 hours ago
17 hours ago
17 hours ago
17 hours ago
May 21, 2024
May 7, 2021
Feb 10, 2025
Sep 13, 2023
Dec 5, 2024
Mar 25, 2024
1 hour ago
14 hours ago
19 hours ago
21 hours ago
20 hours ago
23 hours ago
The gender gap in teenage depression is significantly larger in London compared to Tokyo. In London, the disparity in depressive symptoms between boys and girls begins earlier and increases more rapidly, with the difference by age 16 being twice as large as in Tokyo. While depressive symptoms in Tokyo boys decrease with age, they slightly increase in London, paralleling the trend seen in Tokyo girls. These findings highlight the influence of cultural and social contexts on mental health disparities, suggesting that factors such as socioeconomic conditions and societal roles may contribute to these differences.
This summary was automatically generated using LLM. Full disclaimer
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.

Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
We keep our content available to everyone. Consider supporting Science X’s mission by getting a premium account.
Daily science news on research developments and the latest scientific innovations
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web

source

Leave a Comment

Leave a Comment

Makassar Government Urged To Support Health Insurance For Poor – Evrim Ağacı

Makassar Government Urged To Support Health Insurance For Poor – Evrim Ağacı

In Makassar, the city government is under pressure to assist underprivileged residents with their health insurance contributions.
Ari Ashari Ilham, the Chairman of Commission D of the Makassar City DPRD, has taken a strong stand, advocating for the Makassar City Government (Pemkot) to finance BPJS Kesehatan contributions for low-income individuals. During a statement made on March 18, 2025, Ashari highlighted the grim realities many residents face. He said, “Don’t let people living in Makassar, which is said to be a big city, die because they can’t access health services due to unpaid BPJS fees.”

Ashari’s concern stems from the growing number of underprivileged residents who are unable to pay their BPJS Kesehatan contributions, resulting in significant arrears. He has been proactive about addressing this issue, noting that discussions with BPJS Kesehatan have already occurred, with plans to include the matter in upcoming conversations with the Makassar City Government.
The issue of unpaid health insurance, Ashari argues, could lead to dire consequences for the city’s residents. He pointed out that not everyone in Makassar is financially capable of affording these payments, emphasizing the need for systemic support. Ashari said, “We know that not all residents fall into the category of being able to pay. Those who can’t are still holding BPJS Mandiri, but they cannot pay.”
For him, the role of the government is crucial in resolving this pressing matter. He urged the Makassar City Government to identify the truly underprivileged individuals who qualify for assistance in paying their BPJS Kesehatan contributions. “The government has to take a major role in assessing those who are genuinely in need,” Ashari reiterated. “There should be no obligation for those who are genuinely unable to pay their BPJS contributions to either pay in full or in installments. These fees should be transferred to the KIS.”
Ashari firmly believes that the city’s annual budget (APBD) could accommodate expenses related to BPJS Kesehatan for those in need. “With the large budget we have in Makassar, it’s hard to believe we can’t support genuinely underprivileged individuals’ health insurance.” He also plans to present this issue during the upcoming budget meeting, where he will advocate for solutions to ensure that BPJS arrears from those unable to pay are covered by city funds.
“I will discuss this issue at the budget meeting later, specifically looking for a way to transfer the burdens of BPJS dues for those who genuinely cannot pay into the city’s budget,” he concluded, underlining the urgency of the matter. The potential for an aligned approach between city authorities and health insurance entities could pave the way for improved health access among Makassar’s vulnerable populations.
We’ve launched what we proudly call the “Intelligent Journalism” era: a bold approach to journalism that prioritizes verifiable facts, eliminates unnecessary fluff, restores the rigor of classic journalistic principles, and delivers news in a clear, compelling format—all powered by our innovative AI algorithms.
Support Intelligent Journalism with a tip to help us understand the stories you love most, so we can bring you more of what matters!
We always aim for accuracy, but we recognize that errors can occasionally slip through. We value your feedback and are committed to making corrections whenever needed. If you spot a factual mistake in our stories, please let us know, and we’ll address it promptly.
Please use this feedback form solely for reporting factual errors, rather than for sharing personal opinions. We appreciate your help in keeping our content accurate and reliable.
We always strive for thorough and accurate reporting, and we value any verified information that can help us better understand the stories we cover. If you have relevant knowledge, insights, or evidence related to a news piece we’ve reported, we encourage you to share it with us. Please remember that we require credible proof or documentation to ensure the integrity of our journalism.
When submitting your tip, explain your connection to the case and provide verifiable evidence. This can include links to documents, photographs, recordings, or other supporting materials, as long as they are securely hosted on reputable cloud-based platforms like Google Drive or Dropbox. We cannot accept direct uploads. Please include your contact information (email and phone number) if you would like us to follow up with you regarding your tip. Our editorial team will review your submission, and if necessary, we will reach out for more information. Your help plays a crucial role in helping us deliver accurate, reliable news to the public.
THE PINNACLE GAZETTE, a platform established by Bayesian Tinkering Labs LLC, is your premier source for the latest news across a diverse array of topics. Our website offers comprehensive coverage on science, technology, current events, art, and sports, ensuring that you stay informed and gain fresh perspectives.

source

Leave a Comment

Leave a Comment

Mental health disparity between teenage boys and girls ‘not inevitable’ – study – Bury Mercury

Mental health disparity between teenage boys and girls ‘not inevitable’ – study – Bury Mercury

Mental health disparities between teenage girls and boys are “not inevitable”, experts have said.
The comments come after a new study compared the mental health of teenagers in London and Tokyo.
From early adolescence, girls from both London and Tokyo have higher levels of depression than boys.
But the “disparity is larger”, increases at a faster rate and starts earlier among girls in London.
And experts said that the “trajectory for boys in London closely mirrors the trajectory for girls in Tokyo”.
Researchers said their work suggests that differences in emotional health between teenage boys and girls are “not an inevitable part of teenage development”.
They suggested that if problems are driven by “social and structural factors” then individual solutions – including mindfulness, talking therapies and mental health first aid – are “unlikely to be effective” at resolving differences in emotional health between teenage boys and girls.
The new study, led by experts at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, tracked depressive symptoms in 7,100 people from Tokyo and London.
Experts monitored symptoms at three different points throughout adolescence among children aged 11 to 16.
“We found strong evidence that gender inequalities in depressive symptoms are larger, and might emerge earlier, among young people in London than young people in Tokyo,” the authors wrote in the journal Lancet Child And Adolescent Health.
“Notably, the mean rate of increase in depressive symptoms per year was around four times steeper among girls in London than girls in Tokyo.”
Young researchers who contributed to the study suggested that teenagers in London might assume adult roles and responsibilities at a younger age compared with young people in Tokyo
“In the UK, young girls and those in low income and financially insecure families assume adult responsibilities (eg unpaid care) at younger ages compared with boys and those from more affluent backgrounds,” the authors said, adding that “it is possible that (gendered) differences in young people’s roles and responsibilities in the home and the community contribute to disproportionately high depressive symptoms among girls in London”.
Simply being there for someone can go a really long way.
📷 letstalk.mentalhealth pic.twitter.com/DWxr8x6WDD
— YoungMinds (@YoungMindsUK) March 13, 2025
They said that societal differences may also contribute – for instance violence and “interpersonal crime” is lower in Tokyo than it is in London.
Young people in London may be more likely to experience racism, they said.
“And the UK’s prolonged period of austerity — and related increases in child poverty, inequality, and chronic underfunding of public services supporting young people — is not mirrored in Japan,” the authors added.
The study concludes: “Differences in emotional health between teenage boys and girls are often considered an inevitable part of teenage development; our own and others’ work increasingly suggests this might not be case.
“If high and rising rates of emotional ill-health among girls and young women are largely driven by social and structural factors, then individual-focused interventions (eg, mindfulness, talking therapies, and mental health first aid), which currently dominate the UK’s response to the problem, are unlikely to be an effective solution.
“Our findings suggest gender inequalities in emotional health are context dependent and the steep increases in emotional distress faced by many girls in the UK are not an inevitable part of development.
“There is an urgent need to understand the contexts and conditions that enable young girls to thrive.”
First author Dr Gemma Knowles, from King’s College London, said “Our study suggests that, from around early adolescence onwards, girls have higher levels of depression than boys in both Tokyo and London but the disparity is larger, starts a bit earlier, and increases at a faster rate in London.
“The trajectory for boys in London closely mirrors the trajectory for girls in Tokyo.
“These findings suggest we need to rethink and challenge popular narratives around gender differences in mental health – for example, the idea that girls are naturally or inevitably more likely to struggle with their emotional health – and to understand the contexts and conditions that enable teenage girls and young people to thrive.”
We want our comments to be a lively and valuable part of our community – a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Last Updated:
Are you sure you want to delete this comment?
This website and associated newspapers adhere to the Independent Press Standards Organisation’s Editors’ Code of Practice. If you have a complaint about the editorial content which relates to inaccuracy or intrusion, then please contact the editor here. If you are dissatisfied with the response provided you can contact IPSO here
© 2001-2025. Newsquest Media Group Ltd, 1st Floor, Chartist Tower, Upper Dock Street, Newport, Wales, NP20 1DW | 01676637 |
Data returned from the Piano ‘meterActive/meterExpired’ callback event.
As a subscriber, you are shown 80% less display advertising when reading our articles.
Those ads you do see are predominantly from local businesses promoting local services.
These adverts enable local businesses to get in front of their target audience – the local community.
It is important that we continue to promote these adverts as our local businesses need as much support as possible during these challenging times.

source

Leave a Comment

Leave a Comment

Leave a Comment

VIVUS’ QSYMIA® to be Featured on Health Uncensored with Dr. Drew – GlobeNewswire

VIVUS’ QSYMIA® to be Featured on Health Uncensored with Dr. Drew – GlobeNewswire

 | Source: VIVUS LLC VIVUS LLC
— Segment to air on Lifetime on Wednesday, March 19, at 7:30 AM ET/PT
CAMPBELL, Calif., March 19, 2025 (GLOBE NEWSWIRE) — VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, today announced an exclusive episode on Health Uncensored with Dr. Drew. The episode will feature John Amos, Chief Executive Officer at VIVUS LLC, along with leading weight-loss experts, to discuss QSYMIA® (phentermine and topiramate extended-release capsules CIV), the leading once-daily oral branded, weight-management medication. It is scheduled to air on Lifetime on Wednesday, March 19 at 7:30 AM ET/PT and can also be viewed on Health Uncensored’s website here.
John Amos, Dr. Farhad Zangeneh, Medical Director of Endocrine, Diabetes and Osteoporosis Clinic, Dr. Dina Peralta-Reich, New York Weight Wellness Medicine Founder and Director, and Peter Maher, a QSYMIA patient, will join Dr. Drew Pinsky, host of Health Uncensored, to discuss weight management and the role QSYMIA can play in maintaining a healthy weight and lifestyle.
“Obesity is a major health crisis, contributing to leading causes of death such as heart disease, stroke, and diabetes. With global obesity rates expected to reach one billion by 2030, the need for effective, science-driven solutions has never been more urgent. At VIVUS, and with QSYMIA, we are committed to providing a proven, safe and convenient once-daily oral medication to patients. Our mission is to not only address the complexities of obesity but to drive meaningful change in how it is managed, ensuring better outcomes for millions worldwide,” shared Mr. Amos.
QSYMIA is the leading non-injectable branded weight loss medication in the U.S. for adults. QSYMIA is a combination of phentermine, a sympathomimetic amine anorectic, and topiramate, indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight in some adults and certain pediatric patients aged 12 years and older.
Health Uncensored with Dr. Drew is an innovative, informative and entertaining television series. Dr. Drew Pinsky introduces us to the most important ideas in the new era of health and medicine. From the latest medical breakthroughs to simple home health solutions, Dr. Drew discusses it all with leading experts. Health Uncensored with Dr. Drew topics are timely and compelling, including brain health, emotional resilience, vitality and aging, super foods for cancer prevention, and the “magic pill” of exercise. The program also informs us about the role each of us play in creating a healthier life and world. Dr. Drew brings his insight and knowledge to each episode as he presents a truly global picture of health practices, both new and time-tested. To learn more about Health Uncensored with Dr. Drew, visit https://drdrew.com/health-uncensored-with-dr-drew/. Check your local provider for TV channel listings for Lifetime.
About VIVUS
VIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs. For more information about the Company, please visit http://www.vivus.com.
About QSYMIA
QSYMIA is indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity, and in adults with overweight in the presence of at least one weight-related comorbid condition.
The effect of QSYMIA on cardiovascular morbidity and mortality has not been established. The safety and effectiveness of QSYMIA in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established.
For more information on QSYMIA, please visit https://QSYMIA.com/
Important Safety Information for QSYMIA
Do not take QSYMIA if you are pregnant, planning to become pregnant, or become pregnant during QSYMIA treatment; have glaucoma; have thyroid problems (hyperthyroidism); are taking certain medicines called monoamine oxidase inhibitors (MAOIs) or have taken MAOIs in the past 14 days; are allergic to topiramate, sympathomimetic amines such as phentermine, or any of the ingredients in QSYMIA.
QSYMIA can cause serious side effects, including birth defects (cleft lip/cleft palate), serious eye problems (secondary angle closure glaucoma), visual field defects (independent of elevated intraocular pressure), suicidal thoughts or actions, and severe rash with blisters and peeling skin. QSYMIA may slow the increase in height in children 12 years and older.
Common side effects of QSYMIA in adults include numbness or tingling in the hands, arms, feet, or face (paraesthesia), dizziness, changes in the way foods taste or loss of taste (dysgeusia), trouble sleeping (insomnia), constipation, and dry mouth. Common side effects of QSYMIA in children aged 12 years and older include depression, dizziness, joint pain, fever, flu, and ankle sprain.
For more information, please read the QSYMIA Medication Guide, Full Prescribing Information, and Risk of Birth Defects with QSYMIA patient brochure.
Forward-Looking Statements
Important Information and Cautionary Note Regarding Forward-Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and/or covered by the “Bespeaks Caution” doctrine applied by the courts under the antifraud provisions of the federal securities laws, and other applicable provisions of the federal securities laws. Such forward-looking statements are based on current expectations, management’s beliefs and certain assumptions made by the Company’s management. These statements may be identified by the use of forward-looking words such as “will,” “shall,” “may,” “believe,” “expect,” “forecast,” “intend,” “anticipate,” “predict,” “should,” “plan,” “likely,” “opportunity,” “estimated,” and “potential,” and/or the negative use of these words or other similar words. All forward-looking statements included in this document are based on our current expectations, and the Company assumes no obligation to update any such forward-looking statements except to the extent otherwise required by law.
Forward-looking information about QSYMIA, including its potential benefits, approvals in potential markets outside the U.S. and anticipated product availability, involve substantial risks and uncertainties that could cause actual results to dier materially from those expressed or implied in this press release. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for our clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data; the risk that clinical trial data are subject to diering interpretations and assessments by regulatory authorities; whether regulatory authorities will be satisfied with the design of and results from our clinical studies; whether and when drug applications may be filed in any other markets or approved, whether QSYMIA will be commercially successful; decisions by regulatory authorities impacting labeling, manufacturing processes, safety and/or other matters that could aect the availability or commercial potential of QSYMIA; uncertainties regarding the impact of COVID-19 on our business, operations, and financial results; and competitive developments.
The above factors, risks and uncertainties are difficult to predict, contain uncertainties that may materially affect actual results and may be beyond the Company’s control. New factors, risks and uncertainties emerge from time to time, and it is not possible for management to predict all such factors, risks and uncertainties. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore any of these statements may prove to be inaccurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation or warranty by the Company or any other person that the Company’s objectives and plans will be achieved. These forward-looking statements speak only as of the date such statements were made or any earlier date indicated, and the Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes in underlying assumptions or otherwise, unless otherwise required by law.
Contacts
VIVUS LLC
T: +1 (650) 934-5200
Media – FINN Partners
Glenn Silver
glenn.silver@finnpartners.com 
T: +1 973-818-8198

source

Leave a Comment